Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02060734

Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated Disorder

Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated disorder-a Randomized Controlled Trial

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Hamilton Health Sciences Corporation · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury.

Detailed description

This is a double-blind, randomized controlled trial to determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury. Outcomes include pain, objective assessment, self-report function recovery, impact on work performance and globe perceived effects which will be assessed 5 minutes, 2 and 6 weeks following injection.

Conditions

Interventions

TypeNameDescription
PROCEDURELidocaineLidocaine injection 3-5 points in experimental group( using 25 gauge, 40mm long needle, pre-filled with 1% lidocaine inserting into the site of the trigger point).
OTHERSalineThe control group will receive a 25 gauge, 40mm long needle, pre-filled with saline inserting to subcutis.

Timeline

Start date
2015-10-01
Primary completion
2016-01-01
Completion
2016-09-01
First posted
2014-02-12
Last updated
2017-02-23

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02060734. Inclusion in this directory is not an endorsement.